From Nasdaq: 2025-06-27 18:15:00

In the latest trading session, Doximity (DOCS) closed at $61.09, up 1.13% from the day prior, outperforming the S&P 500. The stock has climbed 16.31% in the past month, exceeding the Medical sector and S&P 500 gains. Doximity is forecasted to report an EPS of $0.31 and revenue of $139.67 million.

Analysts expect Doximity to report a 10.71% increase in EPS and a 10.26% rise in revenue from the prior year’s quarter. The Zacks Consensus Estimates project earnings of $1.46 per share and revenue of $625.72 million for the full year. Recent analyst estimates revisions reflect confidence in Doximity’s performance and profit potential.

Investors should consider Doximity’s valuation metrics, as it currently has a Forward P/E ratio of 41.41, higher than the industry average. The stock also has a PEG ratio of 4.49, indicating a premium compared to the industry average. Doximity is part of the Medical Info Systems industry, which ranks in the top 31% of all industries.

Zacks’ Research Chief Picks Stock Most Likely to “At Least Double.” Director of Research Sheraz Mian believes one stock has superior money-doubling potential. The industry rank of the Medical Info Systems industry is 74 out of over 250 industries, indicating strong performance potential. Zacks Investment Research provides insights and recommendations for stock investors.



Read more at Nasdaq: Doximity (DOCS) Laps the Stock Market: Here’s Why